These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 11156527

  • 1. HER2/neu antisense targeting of human breast carcinoma.
    Roh H, Pippin JA, Green DW, Boswell CB, Hirose CT, Mokadam N, Drebin JA.
    Oncogene; 2000 Dec 11; 19(53):6138-43. PubMed ID: 11156527
    [Abstract] [Full Text] [Related]

  • 2. Antisense oligonucleotides specific for the HER2/neu oncogene inhibit the growth of human breast carcinoma cells that overexpress HER2/neu.
    Roh H, Pippin J, Boswell C, Drebin JA.
    J Surg Res; 1998 Jun 11; 77(1):85-90. PubMed ID: 9698539
    [Abstract] [Full Text] [Related]

  • 3. Down-regulation of HER2/neu expression induces apoptosis in human cancer cells that overexpress HER2/neu.
    Roh H, Pippin J, Drebin JA.
    Cancer Res; 2000 Feb 01; 60(3):560-5. PubMed ID: 10676637
    [Abstract] [Full Text] [Related]

  • 4. 3,3'-diindolylmethane and paclitaxel act synergistically to promote apoptosis in HER2/Neu human breast cancer cells.
    McGuire KP, Ngoubilly N, Neavyn M, Lanza-Jacoby S.
    J Surg Res; 2006 May 15; 132(2):208-13. PubMed ID: 16580691
    [Abstract] [Full Text] [Related]

  • 5. Downregulation of HER2/neu receptor by solamargine enhances anticancer drug-mediated cytotoxicity in breast cancer cells with high-expressing HER2/neu.
    Shiu LY, Liang CH, Huang YS, Sheu HM, Kuo KW.
    Cell Biol Toxicol; 2008 Jan 15; 24(1):1-10. PubMed ID: 17885815
    [Abstract] [Full Text] [Related]

  • 6. The effect of HER-2/neu overexpression on chemotherapeutic drug sensitivity in human breast and ovarian cancer cells.
    Pegram MD, Finn RS, Arzoo K, Beryt M, Pietras RJ, Slamon DJ.
    Oncogene; 1997 Jul 31; 15(5):537-47. PubMed ID: 9247307
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. HER2/neu increases the expression of Wilms' Tumor 1 (WT1) protein to stimulate S-phase proliferation and inhibit apoptosis in breast cancer cells.
    Tuna M, Chavez-Reyes A, Tari AM.
    Oncogene; 2005 Feb 24; 24(9):1648-52. PubMed ID: 15674342
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Down regulation of HER2/neu expression by adenovirus E1A and its anti-tumor activity].
    Lu H, Qin H, Zhang Y.
    Zhonghua Zhong Liu Za Zhi; 2000 Sep 24; 22(5):370-3. PubMed ID: 11778270
    [Abstract] [Full Text] [Related]

  • 12. Targeting human breast cancer cells that overexpress HER-2/neu mRNA by an antisense iron responsive element.
    Yan DH.
    Biochem Biophys Res Commun; 1998 May 19; 246(2):353-8. PubMed ID: 9610362
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. SV40 T/t-common polypeptide specifically induces apoptosis in human cancer cells that overexpress HER2/neu.
    Wen CC, Cheng SA, Hsuen SP, Huang YL, Kuo ZK, Lee HF, Kuo CH, Du JL, Wang WB.
    Cancer Res; 2006 Jun 01; 66(11):5847-57. PubMed ID: 16740724
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Switching off HER-2/neu in a tetracycline-controlled mouse tumor model leads to apoptosis and tumor-size-dependent remission.
    Schiffer IB, Gebhard S, Heimerdinger CK, Heling A, Hast J, Wollscheid U, Seliger B, Tanner B, Gilbert S, Beckers T, Baasner S, Brenner W, Spangenberg C, Prawitt D, Trost T, Schreiber WG, Zabel B, Thelen M, Lehr HA, Oesch F, Hengstler JG.
    Cancer Res; 2003 Nov 01; 63(21):7221-31. PubMed ID: 14612517
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Downregulation of human polo-like kinase activity by antisense oligonucleotides induces growth inhibition in cancer cells.
    Spänkuch-Schmitt B, Wolf G, Solbach C, Loibl S, Knecht R, Stegmüller M, von Minckwitz G, Kaufmann M, Strebhardt K.
    Oncogene; 2002 May 09; 21(20):3162-71. PubMed ID: 12082631
    [Abstract] [Full Text] [Related]

  • 20. Soy isoflavone genistein modulates cell cycle progression and induces apoptosis in HER-2/neu oncogene expressing human breast epithelial cells.
    Katdare M, Osborne M, Telang NT.
    Int J Oncol; 2002 Oct 09; 21(4):809-15. PubMed ID: 12239620
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.